Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Fool me once... saying comes to mind
View:
Post by CdnNewby on Jun 24, 2016 6:36pm

Fool me once... saying comes to mind

Roller,
  As naive as I might be compared to "high rollers" like yourself,  I find it hard to believe that you would think you have any credibility to many of us on this board at this time. CRX is still rated  between hold and buy on sites Ifind. 
I am not a bag holder that will hang on whatever comes our way, but we need to be realistic and not panic at your say so..or Lattice's, or Pineapple's.....
Comment by Roller007 on Jun 24, 2016 6:52pm
Cdnnewby:  my predictions of a buyout are not what drove the SP to $45 June 2nd, it's the reality of what was going on. The manipulators with the false reports and distorting tactics drove it back to $29 and Brexit took it to $27.  All the meanwhile the bo talks are alive and well underway.  Over 12 million shares shorted, the markets were wrong re Brexit and are wrong re Cxr ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities